Quick Answer
ACADIA PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $177.70 million for the year ending 2025.
- ACADIA PHARMACEUTICALS INC showed a decrease of -44.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from ACADIA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $5.56 million | Q2 2012: $9.21 million | Q3 2012: $8.02 million | Q1 2013: $18.44 million | Q2 2013: $24.25 million | Q3 2013: $11.80 million | Q1 2014: $96.46 million | Q2 2014: $13.70 million | Q3 2014: $36.37 million | Q1 2015: $76.42 million | Q2 2015: $93.21 million | Q3 2015: $70.80 million | Q1 2016: $175.22 million | Q2 2016: $131.77 million | Q3 2016: $153.68 million | Q1 2017: $157.38 million | Q2 2017: $143.79 million | Q3 2017: $112.62 million | Q1 2018: $116.33 million | Q2 2018: $74.18 million | Q3 2018: $63.90 million | Q1 2019: $97.56 million | Q2 2019: $74.43 million | Q3 2019: $385.47 million | Q1 2020: $173.06 million | Q2 2020: $310.44 million | Q3 2020: $452.35 million | Q1 2021: $304.49 million | Q2 2021: $266.96 million | Q3 2021: $94.64 million | Q1 2022: $204.92 million | Q2 2022: $139.83 million | Q3 2022: $154.84 million | Q1 2023: $290.90 million | Q2 2023: $107.94 million | Q3 2023: $98.19 million | Q1 2024: $204.75 million | Q2 2024: $177.13 million | Q3 2024: $155.15 million | Q1 2025: $217.70 million | Q2 2025: $253.64 million | Q3 2025: $258.00 million.
- Over the full 16 years of available data (2010 to 2025), ACADIA PHARMACEUTICALS INC's Cash And Cash Equivalents At Carrying Value has grown by 2,494.5%.
- Historical annual values: Fiscal year 2025: $177.70 million | Fiscal year 2024: $319.59 million | Fiscal year 2023: $188.66 million | Fiscal year 2022: $114.85 million | Fiscal year 2021: $147.44 million | Fiscal year 2020: $326.03 million | Fiscal year 2019: $189.68 million | Fiscal year 2018: $134.76 million | Fiscal year 2017: $69.42 million | Fiscal year 2016: $163.62 million | Fiscal year 2015: $102.14 million | Fiscal year 2014: $61.85 million | Fiscal year 2013: $11.71 million | Fiscal year 2012: $57.90 million | Fiscal year 2011: $6.89 million | Fiscal year 2010: $6.85 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: